Alpa Laboratories Ltd Financials
Company Logo

Alpa Laboratories Ltd Financial Statement

Alpa Laboratories Ltd Income Statement

Quarterly

Annual

*All values are in Rs. Cr

Particulars
Sep 2024
Revenue31.85
Operating Expense21.67
Net Profit7.63
Net Profit Margin23.96
Earning Per Share3.63
EBIDTA10.18
Effective Tax Rate19.25

Alpa Laboratories Ltd Profit & Loss

*All values are in Rs. Cr

Standalone

Consolidated

Particulars
Mar 2024
Total Revenue Annual108.74
Operating Expenses Annual100.59
Operating Profit Annual23.02
Interest Annual0.39
Depreciation1.95
Net Profit Annual16.78
Tax Annual3.90

Alpa Laboratories Ltd Cash Flow

*All values are in Rs. Cr

Standalone

Consolidated

Particulars
Mar 2024
Cash Flow at the Beginning10.14
Cash Flow from Operations3.70
Cash Flow from Investing-12.45
Cash Flow from Financing2.26
Cash Flow at the End3.66

Alpa Laboratories Ltd Key Ratios

*All values are in Rs. Cr

Standalone

Consolidated

Particulars
Mar 2024
PBDIT Margin (%)21.17
PBIT Margin (%)19.38
PBT Margin (%)-30.31
Net PROFIT Margin (%)15.43
Return On Networth / Equity (%)10.93
Return On Networth /Employed (%)13.38
Return On Assets (%)10.65
Total Debt / Equity (X)0.03
Asset Turnover Ratio (%)0.69

Alpa Laboratories Ltd Balance Sheet

*All values are in Rs. Cr

Standalone

Consolidated

Particulars
Mar 2024
Fixed Assets Annual11.47
Total Current Assets Annual159.77
Non Current Assets Annual32.65
Total Shareholders Funds Annual161.97
Total Assets Annual192.42

Alpa Laboratories Ltd Earning Calls

EPS (INR)

Expected

3.65

Reported

3.66

Surprise

0.27%

Jun 2024

EPS beaten by 0.27%

Mar 2024

EPS beaten by 0.00%

Dec 2023

EPS beaten by 1.18%

Get Your FAQs Right

As of Dec 26, 2024, Alpa Laboratories Ltd has a market capitalization of 175.49 Cr. Value Research classifies it as a Micro-Cap company.
Yes, Alpa Laboratories Ltd is debt-free with a debt-to-equity ratio of 0.03.
In FY 2023 , Alpa Laboratories Ltd recorded a total revenue of approximately 108.74 Cr marking a significant milestone in the company's financial performance.
Alpa Laboratories Ltd's Future outlook anticipates robust growth, with forecasted earnings and revenue rising approximately 0.1% and -0.0% annually, respectively..
Alpa Laboratories Ltd's current PE ratio is 10.46.
Alpa Laboratories Ltd's ROCE averaged 12.7% from the FY ending March 2022 to 2024, with a median of 12.6%. It peaked at 14.4% in March 2022, reflecting strong capital efficiency over the period..
Alpa Laboratories Ltd's latest EBIT is Rs. 21.06 Cr, surpassing the average EBIT of Rs. 19.01 Cr over the 5 years..

Join the

Future of Trading

with BlinkX

#ItsATraderThing

Open Demat Account
Verify your phone
+91
*By signing up you agree to our terms & conditions